Northwest Biotherapeutics, Inc.
NWBOW
NWBOW was delisted on the 16th of December, 2016.
1 hedge funds and large institutions have $734K invested in Northwest Biotherapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
67% more capital invested
Capital invested by funds: $439K → $734K (+$295K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $737K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Allianz Asset Management
Munich,
Germany
| $734K | – | – | – |
|
|
AIG
2
American International Group
New York
| – | -$7K | -2,640 | Closed |
|
NWBOW Hedge Fund Activity: Q1 2015 in Review
1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q1 2015, worth a combined $734K — up 67% from $439K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NWBOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was American International Group, exiting entirely with an estimated $7K sold.
- 1 institutional investor held Northwest Biotherapeutics, Inc. (NWBOW) as of Q1 2015, down from 2 in Q4 2014.
- Funds reported $734K of Northwest Biotherapeutics, Inc. stock for Q1 2015, up 67% quarter-over-quarter.
- 0 funds opened new Northwest Biotherapeutics, Inc. positions in Q1 2015 and 1 closed out, a net change of -1 holder.
- The largest Northwest Biotherapeutics, Inc. seller in Q1 2015 was American International Group, an estimated $7K sold.
Based on aggregated 13F filings for Q1 2015.